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December 20101738 Abstractsleft groin. Over this spartacore crossover wire the Ansel-1 sheath was
advanced through the fenestration.
The left renal artery was then accessed from the true lumen and an
Atrium iCast stent graft was deployed extending from the true lumen
across the false lumen and into the left renal artery. After confirmation of
left renal perfusion and false lumen exclusion, a stent graft from the left
CIA artery into the external iliac artery was utilized to exclude the distal
CIA fenestration from the true lumen. Due to size constraints, a reversed
Gore iliac limb technique was utilized (20 mm  16 mm  10 mm).
Completion angiogram showed exclusion of the aortic dissection and
normal perfusion into the left kidney. His postoperative studies revealed
a normal renal duplex without stenosis and a postoperative creatinine of
1.2 mg/dl.The Value of a Carotid Duplex Surveillance Program for Stroke
Prevention
Terry Cole, David Cull, Brent Johnson, Eric Walker, Blair Miller, Spence
Taylor, Greenville Hospital System, Greenville, SC
Background: Significant controversy exists regarding the natural his-
tory of asymptomatic carotid stenosis, and the need and appropriate interval
for carotid DU surveillance. The purpose of this study was to determine how
often DU surveillance for asymptomatic carotid stenosis or postCEA re-
sulted in a change in the patient’s clinical management, how many strokes
were prevented by DU surveillance, and the cost of the DU surveillance
program per stroke prevented.
Methods: We reviewed our vascular surgical database to identify all
patients enrolled in a carotid DU surveillance program for asymptomatic
carotid stenosis or following CEA between January 1, 2000 and December
31, 2008. The number of Duplex scans and CEAs performed in those
patients through March 2010 were determined. The results of the Asymp-
tomatic Carotid Atherosclerotic Study were used to estimate the number of
strokes prevented by CEA in the study population. Reimbursement data
were reviewed to calculate the cost of each DU and the cost of the DU
surveillance program for each stroke prevented.
Results: During the study period, there were 11,594 carotid Duplex
scans performed in 3016 patients (mean 3.84 scans per patient) who were
enrolled in a DU surveillance program. Carotid endarterectomy for asymp-
tomatic carotid stenosis was performed in 226 patients. The DU surveillance
program prevented approximately 12 strokes (974 carotid duplex scans per
stroke prevented). The mean allowable cost of each Duplex scan was $332.
The total cost of the DU surveillance program approximated $3,850,000 or
$321,000 per stroke prevented.
Conclusions: Although a routine DU surveillance program generates
substantial revenue, for a vascular surgery practice, its value for stroke
prevention is prohibitively modest. These data support elimination of rou-
tine postendarterectomy surveillance and implementation of amore selective
surveillance process, perhaps targeting patients with carotid stenosis and
factors associated with plaque progression and stroke.
Preoperative Thrombus Load/Location and Type II Endoleak and
Late Sac Regression/Expansion
Ali F. AbuRahma, Albeir Y. Mousa, John E. Campbell, Stephen M. Hass,
Patrick A. Stone, Aravinda Nanjundappa, L. Scott Dean, Tammi Keiffer,
Robert C. Byrd Health Sciences Center of West Virginia University,
Charleston, WV
Background: The correlation of type II endoleak (TIIE) after
endovascular aneurysm repair (EVAR) to aneurysmal sac thrombus load
has only been described once. This study will examine the correlation of
preoperative thrombus load/location to the incidence of TIIE and late
sac regression.
Methods: Prospectively collected data from 266 EVAR patients were
analyzed. Maximum thrombus thickness (MTT) and percentage of throm-
bus-lined aneurysm circumference wall coverage (% TLAC) were deter-
mined from preoperative CTA at four levels: neck, at maximum AAA
diameter (zone B), zone A (between neck and zone B), and zone C
(between zone B and aortic bifurcation). The number of aortic side branches
(ASB) was also recorded (IMA, accessory renals, lumbar, and middle sacral).
Logistic regression was used to determine the association of TIIE with each
variable.
Results:Thirty-three (12%) early and 32 (13%) late TIIE were noted at
amean follow-up of 22months (range: 1-87). ThemeanMTT at zone Bwas
19.7 in patients without early TIIE and 18.8 mm in patients without late
TIIE vs 14.4 and 17.2 mm in patients with early and late TIIE (P  .0137
and .444, respectively). The mean % TLAC was 76% and 75% vs 65% and
64% in patients without vs with early and late TIIE (P  .0329 and .044).
There was no correlation of early and late TIIE and thrombus location (by
zones). IMA was patent in 7% and 7% of patients without early and late TIIE
vs 16% and 15% with TIIE (P .0367 and .077). The mean number of ASB
in patients without (early and late) TIIE was 5.8 and 5.6 vs 5.8 and 7 with
endoleak (P  .932 and .001). Using univariate analysis, the following
variables decreased the incidence of early TIIE: MTT for zone B (OR 0.79
for 5 mm increased (P  .014), MTT zone A (OR 0.78, P  .028), MTT
zone C (O.R. 0.82, P  .043), % TLAC (OR 0.88 for 10% increase, P 
.036), patent IMA (OR 2.6, P .043). For late type II endoleak: % TLAC,
(OR 0.88, for 10% increase P  .048, Fig 1), ASB (OR 1.39 for each
additional vessel, P  .001, Fig 2 and Table). Using multiple regression
model, only ASB (OR 1.34, P .009) was predictor for late TIIE (Table).
Four out of five patients (80%) with late sac expansion vs 24/208 (12%)
without expansion had late TIIE (P  .001).Conclusions: MTT, % TLAC, and number of ASB and patent IMA
influence early TIIE, however only the number of ASB influenced late TIIE.
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thrombus load and aortic side branches and endoleak
Univariate Early type II endoleak Late type II endoleak
Increment OR 95% CI
P
value OR 95% CI
P
value
Neck thickness 5 mm 0.863 0.459-
1.624
.64850.751 0.382-
1.476
.406
Maximum thickness
zone B
5 mm 0.791 0.657-
0.954
.01420.934 0.786-
1.111
.4425
% Thrombus-lined
aneurysm wall
circumference
10% 0.88 0.781-
0.992
.03610.884 0.782-
0.999
.0476
Maximum thickness
zone A
5 mm 0.776 0.624-
0.965
.02270.922 0.751-
1.132
.4358
Maximum thickness
zone C
5 mm 0.824 0.683-
0.994
.043 0.908 0756-
1.091
.303
Aortic side
branches with
patent IMA
1 0.993 0.844-
1.168
.93191.392 1.136-
1.706
.0014
Size of AAA 1cm 0.798 0.530-
1.203
.28160.581 0.361-
0.933
.0248
Multivariate Early type II endoleak Late type II endoleak
Increment OR 95% CI
P
value OR 95% CI
P
value
Neck thickness 5 mm
Maximum thickness
zone B
5 mm 0.843 0.573-
1.241
.3873
% thrombus lined
aneurysm wall
circumference
10% 0.926 0.795-
1.078
.32080.947 0.827-
1.085
.4333
Maximum thickness
zone A
5 mm 0.882 0.512-
1.52
.6513
Maximum thickness
zone C
5 mm 1.16 0.754-
1.785
.5
Aortic side
branches with
patent IMA
1 1.338 1.077-
1.664
.0087
Size of AAA 1 cm 0.71 0.428-
1.178
.1848Endovascular Treatment of Acute and Chronic Aortic Pathology in
Patients With Marfan’s Syndrome
Alyson L. Waterman, Robert J. Feezor, Peter R. Nelson, W. Anthony Lee,
Philip J. Hess, Tomas D. Martin, Thomas S. Huber, Adam W. Beck,
University of Florida, Gainesville, Fla
Background: Aortic dissection and rupture is the main cause of
mortality in patients with Marfan’s syndrome. Although the ascending
aorta must still be managed using open operative techniques, endovas-
cular repair is now available for management of the descending thoracic
and abdominal aorta (TEVAR/EVAR). The short- and long-term benefit
of endovascular repair in Marfan’s patients is unproven. We have sought
to examine our outcomes after endovascular repair in this population.
Methods: Using a database kept at the University of Florida, a retro-
spective review was preformed of all patients with a diagnosis of Marfan’s
syndrome who have undergone TEVAR/EVAR for acute and chronic aortic
pathology. The primary endpoints were in-hospital and overall mortality and
need for additional surgical interventions.
Results: Between January 2004 and June 2010, 16 patients were
identified as having undergone 19 TEVAR/EVAR procedures (one EVAR,
15 TEVAR, and three combined TEVAR/EVAR). The median patient age
at operation was 52 years (range 26-78). Fifteen of 16 patients underwent
surgery of the ascending aorta or arch at a time interval ranging from 17 years
to 1 week prior. Thirteen patients underwent elective TEVAR/EVAR for
chronic dissection and/or aneurysmal dilation of the descending aorta. The
remaining three underwent emergent procedures (two for acute dissection/
malperfusion and one for anastomotic disruption early after open repair).
Three patients underwent secondary TEVARs 6-28 months after their index
TEVAR. Among the 18 TEVARs, 4 required adjunctive endovascular
procedures (1 subclavian artery embolization, 1 vertebral artery stent, 1 renal
artery stent, 1 celiac and SMA stent); all EVARs required complex adjunctive
endovascular procedures involving visceral arteries. During a median fol-
low-up of 32.5 months (range 0-75 months), seven patients (44%) required
subsequent surgical procedures including the three who underwent second
TEVARs (Table). Five patients died during the follow-up period, including
two in the perioperative period (one of whom was the patient who under-
went emergent TEVAR for anastomotic disruption, and one was a patient
who required multi-visceral revascularization in conjunction with his second
TEVAR). Two deaths occurred after discharge (respiratory failure and
cardiac arrest at 3 and 4 months postoperatively). One death was due to
advanced age 6.2 years after EVAR (age 84 at death). In longer-term
follow-up, 11/16 patients are alive and stable (69% overall survival) includ-
ing two who required TEVAR for acute malperfusion, one who required
stentgraft explantation, and four who required other subsequent surgical
procedures (Table).
Conclusion: Aortic disease associated with Marfan’s syndrome is a
complex clinical problem, and endovascular therapy provides a useful ad-
junct to open surgical treatment in some patients. In a select group of
patients, endovascular therapy can be a definitive therapy, however close
